CClinicalTrials.gg
Not yet recruitingNCT04199208PRIOUpdated Apr 9, 2020

Does Prehabilitation Improve Outcome in Coloncancer Surgery?

An interventional study of Prehabilitation and Immunonutrition and Standard Care Arm in Surgery--Complications, sponsored by Region Skane. Not yet recruiting. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2020-04-09.

Sponsored by Region Skane · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Jan 2023, 3 years 9 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

The study aims to find out if complications after surgery for large bowel (colon) cancer can be reduced or avoided in the most frail and elderly by letting them go through an exercise- and diet regime prior to the surgical procedure.

Read the detailed description

All patients with colon cancer who are intended for curative surgery without neoadjuvant chemotherapy who are >=60 years old will be screened with an ergospirometry. The ones that have a ventilate anaerobic threshold (VAT) of less than 11 mg/ml/kg will be included in the study as they are considered extra frail and have a previously proven high risk for complications. These patients will be randomized to standard care or an intervention of prehabilitation consisting of immunonutrition (protein supplement, multivitamin supplement, Selene etc) and an exercise regimen with 4x1 hours per week of cycling on an ergometer. The exercise regimen will be performed in a group of patients and will be led by a physical therapist to ensure compliance. The resistance of the ergometer will be standardized according to the patient's VAT.

The primary outcome measures will be number of and severity of postoperative complications. Secondary outcome measures include quality of life during prehabilitation with repeated measurements during 5 years after surgery, disease-free survival and overall survival.

02

Conditions studied

  • Surgery--Complications

Keywords

  • exercise therapy
  • perioperative period
  • coloncancer
03

In context

Lead sponsor

Region Skane is the lead sponsor of 372 studies on the registry; 113 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 60 years of older
  • Colon cancer diagnosis (macroscopic, microscopic or x-ray diagnosed)
  • Ventilatory Anaerobic Threshold \<11mg/ml/kg
  • Planned open or laparoscopic colectomy due to colon cancer

Exclusion criteria

Exclusion Criteria:

  • Lower extremity amputee
  • Disease requiring radio- and/or chemotherapy prior to surgery/palliative disease
  • Distal metastases (Locoregional lymph nodes are OK)
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
160 participants (estimated)

Study arms

  • Active comparator
    Standard Care Arm

    Standard perioperative care is given.

    Other: Standard Care Arm

  • Experimental
    Interventional Arm

    Intervention of prehabilitation and immunonutrition is given prior to surgery

    Other: Prehabilitation and Immunonutrition

Interventions

  • OtherPrehabilitation and Immunonutrition

    See study synopsis

  • OtherStandard Care Arm

    Standard care as per the daily routines of the Hospital at which the study takes place

06

What researchers measure

Primary outcomes

  1. Complications

    Severity of postoperative complications according do Clavien-Dindo

    Time frame: Assessed when patient is discharged from hospital

  2. Complications

    Number of complication(s) according to POMS

    Time frame: Assessed at postoperative day 5.

Secondary outcomes

  1. Quality of life with SF-36

    Quality of life

    Time frame: At point in time when patient is informed of the cancer, after prehabilitation (just before surgery), 30 days, 2, 3 and 6 months, 1, 3 and 5 years after surgery.

  2. Disease-free survival

    Cancer-free survival Cancer-free survival of the group of the group

    Time frame: 30 and 90 days after surgery, 1, 3 and 5 years after surgery.

  3. Overall survival

    Overall survival of the group (taking all causes of death into account)

    Time frame: 30 and 90 days after surgery, 1, 3 and 5 years after surgery.

07

Study locations

No study locations are listed for this record.

08

References and documents

Study documents

  • Protocol and statistical analysis plan · Jul 10, 2019

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 9, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04199208
Lead sponsor
Region Skane
Responsible party
Sponsor
First posted
Dec 13, 2019
Start date
Oct 1, 2020 (estimated)
Primary completion
Jan 7, 2023 (estimated)
Completion
Jan 7, 2028 (estimated)
Last update
Apr 9, 2020

Study contacts

Stefan Öberg, MD, PhD
Contact
stefan.oberg@med.lu.se
+46424061000
Stefan Öberg, MD, PhD
principal investigator · Region Skåne/Lund University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion